Scientists created a new therapeutic design for glioblastoma, the deadliest form of brain cancer. The lab engineered molecules called trispecifics that connect cancer-killing T cells with not just one ...
European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for Imdylltra (tarlatamab) as monotherapy to treat adults with extensive-stage small cell ...
During its March 2026 meeting, the agency’s Committee for Medicinal Products for Human Use approved treatments for Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer, relapsed ...
Dr. Scott Lowe, Chair of the Cancer Biology and Genetics Program and Scientific Director of the Marie-Josée and Henry R. Kravis Cancer Ecosystems Project, co-led a team that developed a new type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results